Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

by | Jul 24, 2026 | Clinical Trials | 0 comments

​ Conditions: Recurrent Glioblastoma IDH Wildtype; Recurrent Glioblastoma

Interventions: Device: SIR-Spheres®

Sponsors: Olivia Newton-John Cancer Research Institute; Austin Health

Not yet recruiting Conditions: Recurrent Glioblastoma IDH Wildtype; Recurrent Glioblastoma
Interventions: Device: SIR-Spheres®
Sponsors: Olivia Newton-John Cancer Research Institute; Austin Health
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *